{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:33:01Z","timestamp":1719549181901},"reference-count":15,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2006.02.018","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T12:28:35Z","timestamp":1140611315000},"page":"3964-3970","source":"Crossref","is-referenced-by-count":21,"title":["A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age"],"prefix":"10.1016","volume":"24","author":[{"given":"Nicholas","family":"Kitchin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonwen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Hemme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.02.018_bib1","series-title":"Vaccines","first-page":"293","article-title":"Pertussis vaccine","author":"Edwards","year":"1999"},{"key":"10.1016\/j.vaccine.2006.02.018_bib2","first-page":"22","article-title":"Update: vaccine side effects, adverse reactions, contraindications, and precautions after DTP vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR CDC Surveill Summ"},{"issue":"1","key":"10.1016\/j.vaccine.2006.02.018_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"Miller","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.02.018_bib5","series-title":"Immunisation against infectious disease","first-page":"45","year":"1996"},{"issue":"6","key":"10.1016\/j.vaccine.2006.02.018_bib6","first-page":"243","article-title":"Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study","volume":"25","author":"Halperin","year":"2002","journal-title":"Clin Invest Med"},{"issue":"12","key":"10.1016\/j.vaccine.2006.02.018_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","article-title":"Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine","volume":"23","author":"Tejedor","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.02.018_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/biol.1999.0184","article-title":"Overview of recent clinical trials of acellular pertussis vaccine","volume":"27","author":"Miller","year":"1999","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.02.018_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.02.018_bib11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.02.018_bib12","unstructured":"Personal communication, sanofi pasteur."},{"issue":"5","key":"10.1016\/j.vaccine.2006.02.018_bib13","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2006.02.018_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1870(03)00036-0","article-title":"Immunization monitoring program, active: a model of active surveillance of vaccine safety","volume":"14","author":"Scheifele","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.02.018_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.109.1.124","article-title":"Addressing parents\u2019 concerns: do multiple vaccines overwhelm or weaken the infant's immune system?","volume":"109","author":"Offit","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.02.018_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/adc.88.3.222","article-title":"Bacterial infections, immune overload and MMR vaccination","volume":"88","author":"Miller","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2006.02.018_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/bmj.329.7463.411","article-title":"Misconceptions about the new combination vaccine","volume":"329","author":"Bedford","year":"2004","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T15:21:03Z","timestamp":1683386463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X06001770"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.02.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}